Jakafi Xr Tablet, Extended Release
Substitutes & Crosswalk NDC 50881-033

The similar products listed below help you identify alternative medications based on regulatory status, active ingredients, and administration routes. Identify therapeutic equivalents and alternative medications for Jakafi Xr (NDC 50881-033). This cross-referenced list provides clinically relevant matches based on the following criteria:

• Generic Bioequivalence: Products sharing the generic name: Ruxolitinib.
• Administration Consistency: Same Route (oral) and Dosage Form (tablet, extended release).
• Brand Alternatives: Different proprietary names for the same chemical entity.

This clinical crossover tool is designed for healthcare professionals, pharmacists, and patients to safely compare substitute products and manage medication availability.